Clinical Trial Update: Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

Phase 4 evaluation of Chantix (varenicline) for smoking cessation in adults with ADHD; the trial was terminated and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Nicotine Dependence

Drugs mentioned

• CHANTIX (varenicline tartrate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit/Hyperactivity Disorder, Smoking Cessation | Phase 4 | Status: TERMINATED | Results posted: 2013-09-23